Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Targaprimir-96 TFA, a potent inhibitor of microRNA-96 (miR-96) processing, selectively reduces miR-96 production in cancer cells, thereby inducing apoptosis. This compound exhibits low nanomolar affinity binding to primary miR-96 (pri-miR-96), targeting it specifically in breast cancer cells while remaining inactive in normal breast cells [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Targaprimir-96 TFA, a potent inhibitor of microRNA-96 (miR-96) processing, selectively reduces miR-96 production in cancer cells, thereby inducing apoptosis. This compound exhibits low nanomolar affinity binding to primary miR-96 (pri-miR-96), targeting it specifically in breast cancer cells while remaining inactive in normal breast cells [1]. |
Molecular Weight | 1505.77 |
Formula | C79H103F3N18O9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Targaprimir-96 TFA inhibitor inhibit